Volume 13, Number 2—February 2007
Dispatch
Characteristics of Staphylococcus aureus Infections, Chicago Pediatric Hospital
Table 1
Characteristic | Invasive CA-MRSA, n (%) | Invasive CA-MSSA, n (%) | p value |
---|---|---|---|
Race | |||
Black | 16/18 (88) | 3/10 (30) | .01 |
Caucasian | 0 | 2/10 (20) | .01 |
Hispanic | 1/18 (6) | 5/10 (50) | .01 |
Other | 0 | 0 | .01 |
Unknown | 1/18 (6) | 1/10 (10) | .01 |
Days of discordant therapy (CA-MRSA) | |||
Mean ± SD (range) | 2.22 ± 1.76 (0–6) | N/A | |
Days febrile, mean ± SD (range) | 7.0 ± 4 (0–17) | 5.20 ± 10.0 (0–32) | .03 |
Days in hospital, mean ± SD (range) | 14.2 ± 7.6 (4–28) | 13.8 ± 16.8 (4–60) | NS |
Diagnosis† | |||
Osteomyelitis, acute | 3/18 (38) | 1/10 (10) | NS |
Ostyeomyelitis, chronic | 2/18 (11) | 4/10 (40) | NS |
Bacteremia | 5/18 (28) | 2/10 (20) | NS |
Endocarditis | 0/18 (0) | 2/10 (20) | NS |
Pyomyositis | 2/18 (11) | 0/10 (0) | NS |
Liver abscess | 1/18 (6) | 0/10 (0) | NS |
Pneumonia + empyema | 6/18 (33) | 1/10 (10) | NS |
Septic joint | 1/18 (6) | 2/10 (20) | NS |
Fasciitis | 1/18 (6) | 0/10 (0) | NS |
Toxic-shock syndrome | 1/18 (6) | 0/10 (0) | NS |
Other‡ | 3/18 (38) | 0/10 (0) | NS |
Patients with >1 disease manifestation (%) | 7/18 (39) | 1/10 (10) | NS |
Days of illness before hospitalization, mean ± SD (range) | 6.9 ± 11.8 (1–45) | 10.9 d ± 15 (2–45) | NS |
Days of positive cultures, mean ± SD (range) | 6.94 ± 9.9 (1–45) | 4.4 ± 2.98 (1–11) | NS |
Initial leukocyte count‡ (thousand/μL), mean ± SD (range) | 14.8 ± 13.07 (2.4–57.0) | 9.95 ± 4.45 (3.3–17.0) | NS |
*CA-MRSA, community-associated methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive S. aureus; NS, not significant; SD, standard deviation. Among patients with invasive CA-MRSA infection, 1 died.
†Bonferroni correction for multiple comparisons was applied for comparisons of diagnosis.
‡Other diseases included extensive perineal abscess with fistula, subgaleal hematoma, and a subscapular abscess and prostatitis in the same patient. §One initial leukocyte count was unavailable in each patient group.
Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.